Phototoxic or Photoprotective?-Advances and Limitations of Titanium (IV) Oxide in Dermal Formulations-A Review - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue International Journal of Molecular Sciences Année : 2023

Phototoxic or Photoprotective?-Advances and Limitations of Titanium (IV) Oxide in Dermal Formulations-A Review

Résumé

The widespread role of titanium (IV) oxide (TiO2) in many industries makes this substance of broad scientific interest. TiO2 can act as both a photoprotector and photocatalyst, and the potential for its role in both applications increases when present in nanometer-sized crystals. Its sunlightscattering properties are used extensively in sunscreens. Furthermore, attempts have been made to incorporate TiO2 into dermal formulations of photolabile drugs. However, the propensity to generate reactive oxygen species (ROS) rendering this material potentially cytotoxic limits its role. Therefore, modifications of TiO2 nanoparticles (e.g., its polymorphic form, size, shape, and surface modifications) are used in an effort to reduce its photocatalytic effects. This review provides an overview of the potential risks arising from and opportunities presented by the use of TiO2 in skin care formulations.
Fichier principal
Vignette du fichier
ijms-24-08159 TiO2.pdf (1.44 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04087076 , version 1 (02-05-2023)

Licence

Paternité

Identifiants

Citer

Michał Gackowski, Tomasz Osmałek, Anna Froelich, Filip Otto, Raphaël Schneider, et al.. Phototoxic or Photoprotective?-Advances and Limitations of Titanium (IV) Oxide in Dermal Formulations-A Review. International Journal of Molecular Sciences, 2023, 24, pp.8159. ⟨10.3390/ijms24098159⟩. ⟨hal-04087076⟩
8 Consultations
18 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More